Deep profiling of the aggregated proteome in Alzheimer's disease: From pathology to disease mechanisms

23Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Abstract

Hallmarks of Alzheimer's disease (AD), a progressive neurodegenerative disease causing dementia, include protein aggregates such as amyloid beta plaques and tau neurofibrillary tangles in a patient's brain. Understanding the complete composition and structure of protein aggregates in AD can shed light on the as-yet unidentified underlying mechanisms of AD development and progression. Biochemical isolation of aggregates coupled with mass spectrometry (MS) provides a comprehensive proteomic analysis of aggregates in AD. Dissection of these AD-specific aggregate components, such as U1 small nuclear ribonucleoprotein complex (U1 snRNP), provides novel insights into the deregulation of RNA splicing in the disease. In this review, we summarize the methodologies of laser capture microdissection (LCM) and differential extraction to analyze the aggregated proteomes in AD samples, and discuss the derived novel insights that may contribute to AD pathogenesis.

Cite

CITATION STYLE

APA

Lutz, B. M., & Peng, J. (2018, December 1). Deep profiling of the aggregated proteome in Alzheimer’s disease: From pathology to disease mechanisms. Proteomes. MDPI AG. https://doi.org/10.3390/proteomes6040046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free